1. Multiple Targeting of HSP Isoforms to Challenge Isoform Specificity and Compensatory Expression
    Kisho Ono et al, 2023, Chaperones CrossRef
  2. Discovering Anti-Cancer Drugs via Computational Methods
    Wenqiang Cui et al, 2020, Frontiers in Pharmacology CrossRef
  3. Novel matrinic acid derivatives bearing 2‐anilinothiazole structure for non‐small cell lung cancer treatment with improved Hsp90 targeting effect
    Yiming Xu et al, 2022, Drug Development Research CrossRef
  4. Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation
    Zhigao Niu et al, 2021, Journal of Cardiothoracic Surgery CrossRef
  5. Targeted Inhibition of Hsp90 in Combination with Metformin Modulates Programmed Cell Death Pathways in A549 Lung Cancer Cells
    Adria Hasan et al, 2023, Applied Biochemistry and Biotechnology CrossRef
  6. Proteomic Research on the Antitumor Properties of Medicinal Mushrooms
    Boris Jakopovic et al, 2021, Molecules CrossRef
  7. Proteomic Research on the Therapeutic Properties of Medicinal Mushrooms
    Boris Jakopovic et al, 2023, Mushrooms with Therapeutic Potentials CrossRef
  8. Uncovering the Anti-Lung-Cancer Mechanisms of the Herbal Drug FDY2004 by Network Pharmacology
    Ho-Sung Lee et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  9. Deciphering the Precise Target for Saroglitazar Associated Antiangiogenic Effect: A Computational Synergistic Approach
    Swarna Dabral et al, 2023, ACS Omega CrossRef
  10. Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach
    He Zhang et al, 2021, Frontiers in Oncology CrossRef
  11. Functional redundancy of HSPA1, HSPA2 and other HSPA proteins in non-small cell lung carcinoma (NSCLC); an implication for NSCLC treatment
    Damian Robert Sojka et al, 2019, Scientific Reports CrossRef
  12. Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer
    Savvas Papageorgiou et al, 2022, Cancers CrossRef
  13. The Antileukemic and Anti-Prostatic Effect of Aeroplysinin-1 Is Mediated through ROS-Induced Apoptosis via NOX Activation and Inhibition of HIF-1a Activity
    Shou-Ping Shih et al, 2022, Life CrossRef
  14. The Antileukemic Effect of Xestoquinone, A Marine-Derived Polycyclic Quinone-Type Metabolite, Is Mediated through ROS-Induced Inhibition of HSP-90
    Kuan-Chih Wang et al, 2021, Molecules CrossRef